Total Funding
15
35
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
194886
Visant Medical develops a patented and proprietary approach to dry eye treatment.
Mark Packer: Medical MonitorPast Role: International Biomedical Devices, Chief Medical Officer
Past Role: Sharklet Technologies, Vice President Research & Development
About the Company
Visant Medical develops a patented and proprietary approach to dry eye treatment. Visant Medical has exclusive rights to issued patents on the technology.
The logic behind blocking the outflow of tears with plugs is fundamentally sound, as it promotes the retention of the patient’s own tear film to lubricate the eyes, rather than using artificial
tears, which lack the vital components of natural tears. Unfortunately, all of the current methods of blocking the tear ducts have a number of inherent problems. The Visant Medical product addresses virtually all of these problems.
The company was founded in 2017 and is based in Menlo Park, California.
